These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27156511)

  • 1. [Repeated Cerebellar Hemorrhage Related to Rivaroxaban and Apixaban: A Case Report].
    Yokoi M; Toyama Y; Tsurusaki Y; Nakamura A; Mima Y; Kuwashiro T; Wakugawa Y; Yasaka M; Okada Y
    Brain Nerve; 2016 May; 68(5):573-7. PubMed ID: 27156511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Apixaban-Related Convexal Subarachnoid Hemorrhage:A Case Report].
    Shimizu K; Yuki K; Sadatomo T; Hara T; Ohba H; Kurisu K
    No Shinkei Geka; 2016 Mar; 44(3):239-44. PubMed ID: 26965066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation.
    Rillig A; Lin T; Plesman J; Heeger CH; Lemes C; Metzner A; Mathew S; Wissner E; Wohlmuth P; Ouyang F; Kuck KH; Tilz RR
    J Cardiovasc Electrophysiol; 2016 Feb; 27(2):147-53. PubMed ID: 26464027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous Hemopericardium in a Patient Receiving Apixaban Therapy: First Case Report.
    Sigawy C; Apter S; Vine J; Grossman E
    Pharmacotherapy; 2015 Jul; 35(7):e115-7. PubMed ID: 26095120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
    Harenberg J; Marx S; Diener HC; Lip GY; Marder VJ; Wehling M; Weiss C
    Int Angiol; 2012 Aug; 31(4):330-9. PubMed ID: 22801398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Exchange for Urgent Apixaban Reversal in a Case of Hemorrhagic Tamponade after Pacemaker Implantation.
    Lam WW; Reyes MA; Seger JJ
    Tex Heart Inst J; 2015 Aug; 42(4):377-80. PubMed ID: 26413023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of apixaban in the patients undergoing the ablation of atrial fibrillation.
    Nagao T; Inden Y; Shimano M; Fujita M; Yanagisawa S; Kato H; Ishikawa S; Miyoshi A; Okumura S; Ohguchi S; Yamamoto T; Yoshida N; Hirai M; Murohara T
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):155-63. PubMed ID: 25487164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiology Patient Pages: Antidotes for Bleeding Caused by Novel Oral Anticoagulants.
    Pollack CV
    Circulation; 2016 Jan; 133(2):e18-9. PubMed ID: 27028439
    [No Abstract]   [Full Text] [Related]  

  • 9. Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups.
    Lip GY; Mitchell SA; Liu X; Liu LZ; Phatak H; Kachroo S; Batson S
    Int J Cardiol; 2016 Feb; 204():88-94. PubMed ID: 26655548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-activated prothrombin complex concentrates for major bleeding in patients on apixaban and rivaroxaban.
    Sheikh-Taha M
    Intern Emerg Med; 2020 Sep; 15(6):1123-1124. PubMed ID: 31664661
    [No Abstract]   [Full Text] [Related]  

  • 11. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
    Lip GY; Larsen TB; Skjøth F; Rasmussen LH
    J Am Coll Cardiol; 2012 Aug; 60(8):738-46. PubMed ID: 22575324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
    Mantha S; Ansell J
    Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous thrombolysis for stroke in patients taking non-VKA oral anticoagulants: an update.
    Cappellari M; Bovi P
    Thromb Haemost; 2015 Aug; 114(2):440-4. PubMed ID: 25809649
    [No Abstract]   [Full Text] [Related]  

  • 14. Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study.
    Di Biase L; Lakkireddy D; Trivedi C; Deneke T; Martinek M; Mohanty S; Mohanty P; Prakash S; Bai R; Reddy M; Gianni C; Horton R; Bailey S; Sigmund E; Derndorfer M; Schade A; Mueller P; Szoelloes A; Sanchez J; Al-Ahmad A; Hranitzky P; Gallinghouse GJ; Hongo RH; Beheiry S; Pürerfellner H; Burkhardt JD; Natale A
    Heart Rhythm; 2015 Jun; 12(6):1162-8. PubMed ID: 25728754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity.
    Siegal DM; Curnutte JT; Connolly SJ; Lu G; Conley PB; Wiens BL; Mathur VS; Castillo J; Bronson MD; Leeds JM; Mar FA; Gold A; Crowther MA
    N Engl J Med; 2015 Dec; 373(25):2413-24. PubMed ID: 26559317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of apixaban-associated subdural hematoma: a case report on the use of factor eight inhibitor bypassing activity.
    Rinehart DR; Lockhart NR; Hamilton LA; Langdon JR; Rowe AS
    Crit Care Med; 2015 Jun; 43(6):e203-7. PubMed ID: 25738855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal intracerebral bleeding under rivaroxaban.
    Stöllberger C; Bastovansky A; Finsterer J
    Int J Cardiol; 2015 Dec; 201():110-2. PubMed ID: 26296048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embolic stroke during apixaban therapy for left atrial appendage thrombus.
    Ohyagi M; Nakamura K; Watanabe M; Fujigasaki H
    J Stroke Cerebrovasc Dis; 2015 Apr; 24(4):e101-2. PubMed ID: 25620711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban].
    Meddahi S; Samama MM
    J Mal Vasc; 2014 May; 39(3):183-94. PubMed ID: 24650612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of rivaroxaban anticoagulation and spontaneous vitreous hemorrhage.
    Jun JH; Hwang JC
    JAMA Ophthalmol; 2015 Oct; 133(10):1184-6. PubMed ID: 26111247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.